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Bacterial resistance to antibiotics is a major concern worldwide, leading to an extensive
search for alternative drugs. Promising candidates are antimicrobial peptides (AMPs),
innate immunity molecules, shown to be highly efficient against multidrug resistant
bacteria. Therefore, it is essential to study bacterial resistance mechanisms against
them. For that purpose, we used experimental evolution, and isolated a Salmonella
enterica serovar typhimurium-resistant line to the AMP 4DK5L7. This AMP displayed
promising features including widespread activity against Gram-negative bacteria and
protection from proteolytic degradation. However, the resistance that evolved in the
isolated strain was particularly high. Whole genome sequencing revealed that five
spontaneous mutations had evolved. Of these, three are novel in the context of acquired
AMP resistance. Two mutations are related to the AcrAB-TolC multidrug efflux pump.
One occurred in AcrB, the substrate-binding domain of the system, and the second
in RamR, a transcriptional regulator of the system. Together, the mutations increased
the minimal inhibitory concentration (MIC) by twofold toward this AMP. Moreover, the
mutation in AcrB induced hypersusceptibility toward ampicillin and colistin. The last
mutation occurred in Skp, a periplasmic chaperone that participates in the biogenesis
of outer membrane proteins (OMPs). This mutation increased the MIC by twofold to
4DK5L7 and by fourfold to another AMP, seg5D. Proteomic analysis revealed that
the mutation abolished Skp expression, reduced OMP abundance, and increased
DegP levels. DegP, a protease that was reported to have an additional chaperone
activity, escorts OMPs through the periplasm along with Skp, but is also associated
with AMP resistance. In conclusion, our data demonstrate that both loss of Skp and
manipulation of the AcrAB-TolC system are alternative strategies of AMP acquired
resistance in Salmonella typhimurium and might represent a common mechanism in
other Gram-negative bacteria.
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INTRODUCTION
Antimicrobial peptides (AMPs) are innate immunity molecules
that exist in all life forms and act as the first line of
defense against microorganisms. Antimicrobial peptides are
mostly cationic, hydrophobic, and amphipathic, properties that
facilitate their interaction and disruption of the polyanionic
bacterial membranes (Shai, 2002; Zasloff, 2002). Accumulating
evidence over the past two decades indicates that AMPs can
be efficient against antibiotics-resistant bacteria (Lam et al.,
2016; Mahlapuu et al., 2016; Chen et al., 2018; Lazar et al.,
2018; Tucker et al., 2018). This makes them promising
candidates as alternative antibiotics. Because AMPs might serve
as future drugs and several AMPs are under clinical trials
(Naafs, 2018), it is important to study bacterial resistance
mechanisms against them.
Resistance to AMPs in Gram-negative bacteria is mediated
mainly by surface modifications (Nuri et al., 2015), efflux pumps
(Shafer et al., 1998), proteolytic degradation (Mattiuzzo et al.,
2014), and biofilm formation (Kai-Larsen et al., 2010). Salmonella
enterica serovar typhimurium is a model organism used to
study resistance mechanisms toward AMPs. This bacterium
has evolved to survive host environments containing AMPs
within the small intestine and the phagosome (Gunn, 2008;
Dalebroux and Miller, 2014). In vivo resistance to AMPs
in S. typhimurium is known to be mediated by the two-
component signal transduction systems (TCSs) PhoP-PhoQ
(PhoPQ) or PmrA-PmrB (PmrAB). The PhoPQ TCS is activated
in the presence of AMPs, low pH, or low Mg2+, whereas
the PmrAB is induced by low pH, high Fe3+/Al3+, or
by the PhoPQ system. Activation of both systems induces
transcription of genes, eventually mediating lipopolysaccharide
(LPS) modifications (Gunn, 2008), which are considered
among the major resistance mechanisms against AMPs in
S. typhimurium. These modifications mostly reduce the net
negative surface charge, hence the electrostatic interactions
between cationic AMPs and the bacterial anionic cell envelope
(Matamouros and Miller, 2015; Nuri et al., 2015). Another
strategy for LPS modification is lipid A palmitoylation by
the PagP enzyme. This increases the hydrophobic interactions
between the lipid A chains, thus altering the outer membrane
fluidity, making it less permeable to AMPs (Guo et al., 1998;
Bishop et al., 2000). Other reported resistance mechanisms
involve the Sap efflux pump (Parra-Lopez et al., 1993) and
proteolytic degradation by PgtE (Guina et al., 2000).
In the search for novel resistance mechanism of
S. typhimurium to AMPs, we isolated a resistant line [resistant
line 1 (RL1)] to the AMP 4DK5L7 by means of experimental
evolution. This AMP is composed of five lysines and seven
leucines, in which four of these amino acids were replaced by
their D-enantiomers. We have shown previously that 4DK5L7 is
highly potent against Gram-negative bacteria and non-hemolytic
(Papo and Shai, 2005). Despite the promising properties of
4DK5L7, we found that the S. typhimurium isolate RL1 evolved
high constitutive resistance toward this AMP. Genetic analysis
revealed that RL1 carries five mutations in five loci. The first
two mutations were found to be in the yeiU and the rfaY genes,
which encode LPS biosynthesis enzymes. Specifically, yeiU and
rfaY encode enzymes that add a phosphate group to the LPS
lipid A (Touze et al., 2008) or to the LPS core (Heinrichs et al.,
1998; Yethon et al., 1998), respectively. Loss of function or
inhibition of these two genes was previously reported to confer
resistance toward AMPs by reduction of the surface net negative
charge (Herrera et al., 2010; Kato et al., 2012; Lofton et al.,
2013). Interestingly, the other three mutations that we identified
were never reported in the context of AMP acquired resistance.
Two of the mutations are related to the AcrAB-TolC system,
a multidrug resistance efflux pump that was mostly shown to
expel antibiotics, bile salts, and dyes in Gram-negative bacteria
(Yu et al., 2003; Pos, 2009). In Escherichia coli (E. coli) (Warner
and Levy, 2010) and in Klebsiella pneumoniae (K. pneumoniae)
(Padilla et al., 2009), deletion of AcrB, the substrate-binding
domain of the system, caused susceptibility to AMPs. We found
that RL1 carries a mutation within the genes for AcrB and
RamR, a transcriptional repressor of AcrB expression (Abouzeed
et al., 2008). The last mutation in RL1 is in a gene encoding
the periplasmic chaperone Skp. This chaperone is involved in
the biogenesis of outer membrane proteins (OMPs), escorting
them through the periplasmic space toward the outer membrane
(Sklar et al., 2007).
In this study, we evaluated the contribution of the mutations
in AcrB, RamR, and Skp to AMP resistance. We found that
introducing these mutations induced hyposensitivity toward the
4DK5L7 peptide. Moreover, the Skp mutation, which led to the
loss of Skp, induced hyposensitivity to other AMPs as well. While
Skp was mostly characterized in E. coli in the context of OMP
biogenesis, we reveal that this gene plays a role in resistance to
AMPs in S. typhimurium and hence might represent a common
resistance mechanism in Gram-negative bacteria.
MATERIALS AND METHODS
Peptide Synthesis and Purification
Peptides were synthesized by an automated peptide synthesizer
liberty blue (CEM, Matthews, NC, United States) on rink
amide 0.68 mmol/mg MBHA resin, using the Fmoc solid
phase strategy. The resin-bound peptide was washed thoroughly
with dimethylformamide and then dichloromethane, dried, and
cleaved. Lipid groups were conjugated at this stage. Cleavage
was done by addition of 95% trifluoroacetic acid (TFA), 2.5%
water, and 2.5% triethylsilane. The crude peptides were purified
by reverse-phase high-performance liquid chromatography.
Purification of the peptides was done using a C4 or a C8
column (Grace Discovery Sciences, Columbia, MD, United
States) in acetonitrile in water gradient (both containing 0.1%
TFA) for 40 min.
Bacterial Strains and Growth Condition
All S. typhimurium mutant strains used were derived from the
ATCC 14028s background. Generally, cells were grown overnight
in LB and before every experiment were regrown by a dilution of
1:100 into fresh sterile LB medium and incubated at 37◦C with
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agitation for 2 h to reach a mid-log phase (OD600 nm = 0.5–0.7),
unless mentioned differently.
Experimental Evolution and RL1 Isolation
The experimental selection assay was carried out in 96-well plates
at a final volume of 100 µL as previously described (Lofton
et al., 2013) with several alterations. The 4DK5L7 peptide was
dissolved in double distilled water (DDW) to the appropriate
concentration, and 5 µL of the peptide was added to 45 µL
of Mueller-Hinton broth (MHB) in a flat-bottom 96-well plate
(four replicates). Five microliters of DDW was used only for the
wild type (WT) as a negative control. Fifty microliters of WT
S. typhimurium culture (approximately 105 bacteria/mL) in MHB
was added to the peptide-containing 96-well plate. The plate was
incubated at 37◦C with shaking for approximately 24 h. Every
day, 10 µL of bacteria from each lineage was transferred to 90 µL
of a fresh medium containing peptides, in a new 96-well plate.
After transfer, 10 µL of 70% glycerol was added to each culture
in the old plate, and the 96-well plates were kept at −80◦C. If
the bacteria in a well did not grow after transfer, the lineage was
restarted from the most recent passage that showed successful
growth. When a lineage survived three subsequent transfers, the
peptide concentration was increased by 50% for approximately
30 passages. RL1 was isolated from the well in which the maximal
concentration of a peptide was achieved. Bacteria were spread on
LB agar plate, and a single colony was collected. The colony was
grown in liquid LB for three passages without a peptide, and then
the minimal inhibitory concentration (MIC) was determined.
MIC Determination
Mid-log cultures (OD600 = 0.5–0.7) were adjusted to final OD600
of 0.005 in MHB. Peptides or antibiotics were dissolved in DDW
and added to the MHB for the appropriate final concentration.
Plates were incubated for 18 h at 37◦C with agitation. Inhibition
of growth was determined by absorbance measurements at
600 nm using a microplate autoreader. Alternatively, absorbance
at 600 nm was measured at 37◦C with agitation, every 20 min
for 18 h in Cytation 5 plate reader (BioTek, Winooski, VT,
United States) to evaluate the growth curves. Growth rates were
calculated using the R package “growth rates” according to Kahm
et al. (2010). Data were filtered for growth (OD600 > 0.2),
and growth rates for data sets not reaching that threshold
were set to zero.
Whole Genome Sequencing
DNA was purified from the control strain and RL1 overnight
cultures using the DNeasy Blood & Tissue Kits (Qiagen,
Germany). Sequencing was performed on an Illumina MiSeq
platform, as previously described (Blecher-Gonen et al., 2013)
with the following modifications: 300 to 600 ng of gDNA
was sheared using the Covaris E220X sonicator (Covaris, Inc.,
Woburn, MA, United States). End repair was performed in 80-
µL reaction at 20◦C for 30 min, followed by Agencourt AmPURE
XP beads cleanup (Beckman Coulter, Inc., Indianapolis, IN,
United States) in a ratio of 0.75 × beads/DNA volume. A-bases
were added to both 3′ ends, followed by adapter ligation in a
final concentration of 0.125 µM. An SPRI bead cleanup in a
ratio of 0.75 × beads/DNA volume was performed, followed by
eight polymerase chain reaction (PCR) cycles using 2 × KAPA
HiFi ready mix (Kappa Biosystems, Inc., Wilmington, MA,
United States) in a total volume of 25 µL with the following
program: 2 min at 98◦C, eight cycles of 20 s at 98◦C, 30 s
at 55◦C, and 60 s at 72◦C followed by 72◦C at 10 min.
Sequencing QC was performed using fastqc website. Reads
were mapped to S. typhimurium strain 14028s genome version
ASM2216v1 using BWA-MEM v0.7.12-r1039 (Li and Durbin,
2009), sorted using SAMtools v1.2 website. Polymerase chain
reaction duplicate reads were identified and marked using Picard
MarkDuplicates. GATK HaplotypeCaller v3.5 (McKenna et al.,
2010) was used to discover single-nucleotide polymorphisms
(SNPs) and insertions/deletions, using the setting-ploidy 10 in
order to increase sensitivity to subclonal variants. The resulting
variants were hard filtered using standard GATK filters for base
quality, strand bias, and so on. Variant allele fractions for each
variant and each sample were computed from the allelic depths
field in the VCF. Variants were annotated for predicted effect
using snpEFF (Cingolani et al., 2012).
RNA Isolation and Quantitative Reverse
Transcriptase-PCR
RNA was purified from cells at the mid-log stage. Cells were
centrifuged at 4,000 revolutions/min for 10 min. The pellet was
resuspended with 150 µL of fresh 2 mg/mL lysozyme (Sigma,
Germany), Tris 1M, EDTA 0.5M, pH 8.0. Following incubation
of 3 to 5 min at 37◦C, 1 mL of Tri-reagent (Sigma, Germany) was
added. The mixture was vortexed for 10 s at maximum speed and
then incubated at room temperature for 5 min. After addition of
200 µL chloroform, the mixture was vortexed until homogeneity.
The mixture was incubated at room temperature for 5 min until
phase separation has appeared and subsequently centrifuged at
12,000 g for 15 min at 4◦C. The upper phase was collected into
a new tube, and 500 µL of isopropanol was added. The tube was
inverted gently and incubated at room temperature for 10 min
and then at −20◦C for 30 min. The mixture was centrifuged at
maximum speed for 25 min. The pellet was washed twice with
70% ethanol and left to dry. The pellet was resuspended in 30 µL
of DDW and incubated at 55◦C for 10 min until completely
dissolved. One microgram of the RNA was reverse transcribed
using Superscript II reverse transcriptase (Invitrogen, Carlsbad,
CA, United States), dNTPs, and random hexamers. Quantitative
reverse transcriptase (qRT)–PCR was performed in 7300 Real
time PCR system (Applied Biosystems) with Platinum SYBR
Green qPCR Super Mix-UDG with ROX (Invitrogen). The qRT-
PCR was performed in duplicates, three biological replicates in
one plate. The values were normalized to the gyrB gene.
Reconstruction of the Mutated Genes in
the Control Strain and HA Epitope
Tagging of AcrB
Point mutations and HA epitope tagging in the bacterial genome
were performed using the pWRG730 and pWRG717 constructs,
as described previously (Hoffmann et al., 2017). Briefly, the
ISceI + kanamycin cassette was amplified from the pWRG717
plasmid with primers containing homology parts to the target
gene (see primers information in Supplementary Table S1).
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Salmonella typhimurium carrying the pWRG730 were grown to
an OD600 = 0.4–0.5, and λ red recombinase expression was
induced by incubation at 42◦C for 12.5 min and then transferred
to ice for 15 min. The cells were prepared for electroporation by
three washes in 10% ice-cold glycerol. The pellet was resuspended
in 100 µL of 10% glycerol, and 50 to 100 ng of the PCR product
was added. The cells were electroporated and were recovered
in LB at 30◦C for 1 h. Then, they were selected on kanamycin
plates, and positive clones for homologous recombination were
chosen. A 300-bp fragment was amplified from RL1 genome,
designed to contain the point mutation or the epitope tag.
Expression of the λ red recombinase was induced in the positive
clones as described above. Next, the clones were electroporated
with the 300-bp fragment containing the point mutation or the
HA epitope tag. Cells were selected on chloramphenicol plates
containing 100 ng/mL anhydrotetracycline. Positive clones were
verified by colony PCR and sequencing.
Western Blot Analysis
Cells were grown to mid-log stage, and OD600 nm was checked.
For OD600 nm of less than 0.5, 1 mL of culture was collected; for
0.5 < OD600 nm < 1, 0.5 mL of culture was collected, and for
OD600 nm > 1, 0.25 mL was collected. Cells were centrifuged at
6,000 g for 10 min, at 4◦C. The supernatant was removed, and the
pellet was resuspended in 1× sample buffer (Tivan-Biotech, Kfar
Sava, Israel) according to the following formula: sample buffer vol
(mL) = 0.5 × vol sample × OD600 nm. The samples were heated
to 95◦C for 10 min, cooled down on ice, and were loaded on 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel,
110 V. Proteins were transferred to a polyvinylidene difluoride
membrane using wet transfer overnight at 30 V. The blots
were blocked for 1 h in TBST + 5% milk, washed with TBST,
and incubated overnight at 4◦C with an anti-HA antibody
(C29F4) rabbit Mab #3724 (Cell Signaling Technology, Danvers,
MA, United States). The blots were washed three times with
TBST and incubated for 1 h with goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (Jackson Immuno
Research Laboratories, Inc., West Grove, PA, United States) The
treated blots were developed on an enhanced chemiluminescence
detection system with LuminataTM Crescendo Western HRP
substrate (Merck Millipore, Burlington, MA, United States). For
the housekeeping gene, the blots were incubated with anti GroEL
antibody produced in rabbit (Sigma). Quantification of bands
intensity was performed in ImageJ software1.
Proteomic Analysis
Cells were grown to mid-log phase, centrifuged at 4,000 g
for 5 min, and pellet was frozen on dried ice. The samples
were subjected to lysis and in solution tryptic digestion using
the S-Trap method [by ProtiFi (Huntington, New York, NY,
United States)]. The resulting peptides were analyzed using
nanoflow liquid chromatography (nanoAcquity) coupled to
high-resolution, high-mass-accuracy mass spectrometry (Q-
Exactive HFX). Each sample was analyzed on the instrument
separately in a random order in discovery mode. Raw data
were processed with MaxQuant (Cox and Mann, 2008).
1imagej.nih.gov/ij/
The data were searched with the Andromeda search engine
against the S. typhimurium 14028s proteome database
appended with common laboratory protein contaminants
and the following modifications: fixed modification—cysteine
carbamidomethylation; variable modifications—methionine
oxidation, asparagine, and glutamine deamidation. For the
single-gene analysis, the quantitative comparisons were
calculated using Perseus (Tyanova et al., 2016). Decoy hits
were filtered out. Only proteins that had at least two valid
values in at least one experimental group were kept. Pathway
enrichment analyses were done on the basis of the current Kyoto
Encyclopedia of Genes and Genomes (KEGG) annotation of the
S. typhimurium ATCC 14028s genome (“seo”) using the package
“clusterProfiler” (Yu et al., 2012) in “R” v3.512.
RESULTS
RL1 Isolation and Characterization
RL1 was isolated in our laboratory using experimental evolution.
The WT S. typhimurium, with a MIC of 12.5 µM (Table 1)
were exposed to a sub-inhibitory concentration (0.5 × MIC)
of the 4DK5L7 peptide. Following three successful passages, we
increased the concentration by 50%. In total, 30 passages were
conducted, and the maximal concentration in which bacteria
exhibited growth was 160 µM (12.8 × MIC) (Table 1). As
a control, we passaged the WT bacteria with DDW at the
equivalent volume to the peptide for the same amount of
passages. From the last passage, we isolated a single colony, which
was then grown in the absence of the peptide for 3 days. The
isolate that was passaged with 4DK5L7 was named RL1, and
the isolate that was passaged with DDW instead of the peptide
and will be used in our further experiments was named “control
strain.” Next, we tested the MIC of the control strain and RL1 for
the 4DK5L7 peptide and to other AMPs: seg5D, C8-K5L7, and
colistin (Table 2). We found that RL1 exhibited a high resistance
level toward 4DK5L7, as the MIC was 200 µM compared to
12.5 µM in the control strain (Table 1). Moreover, RL1 showed
cross-resistance toward another AMP, seg5D, a synthetic AMP
that was designed in our laboratory (Papo et al., 2002). RL1
showed a MIC of 50 µM compared to 6.25 to 12.5 µM in
the control strain (Table 1). RL1 showed hyposensitivity toward
the cyclic lipopeptide colistin of the polymyxin family and to
the synthetic lipopeptide C8-K5L7. RL1’s MIC to colistin was
detected as 6.25 versus 1.56 to 3.125 µM in the control strain
and to C8-K5L7 6.25 to 12.5 versus 6.25 µM in the control
strain (Table 1).
Whole Genome Sequencing of RL1
Reveals Five Mutations
In order to investigate the mutations that were acquired in RL1,
DNA was purified from the control strain and RL1 bacteria, and
whole genome sequencing was performed. While no mutations
occurred in the control strain, RL1 carried five mutations in
five loci: hlpA (skp), acrB, ramR, yeiU, and rfaY (Table 3).
hlpA (histone-like protein A) encodes the Skp chaperone that
2https://www.r-project.org/
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TABLE 1 | Bacterial strains used in this study and their MICs.
Bacterial strain Relevant characteristics/genotypea,b,c Source 4DK5L7 MIC (µM) seg5D MIC (µM) Colistin MIC (µM) C8-K5L7 MIC (µM)
WT S. typhimurium 14028s ATCC 6.25–12.5 6.25–125 3.125 6.25
Control strain skpWT, ramRWT, acrbWT, yeiUWT, rfaYWT This study 12.5 6.25–12.5 1.56–3.125 6.25
RL1 skp, ramR, acrb, yeiU, rfaY This study 200 50 6.25 6.25–12.5
acrB mut acrB This study 12.5 6.25 ND ND
Double mutant acrB, ramR This study 25 6.25–12.5 1.56 6.25
ramR mut ramR This study 12.5 6.25 ND ND
skp mut Skp This study 25 50 3.125 6.25
Triple mutant skp, ramR, acrB This study 50 50 3.125 6.25
Control strain HA acrbWT-HA This study 12.5 ND ND ND
RL1 HA skp, ramR, acrb-HA, yeiU, rfaY This study >50 ND ND ND
acrB mut HA acrb-HA This study 12.5 ND ND ND
Double mutant HA ramR, acrb-HA This study 25 ND ND ND
ramR mut HA ramR, acrbWT-HA This study 12.5 ND ND ND
a Italics indicate on a point mutation in the mentioned gene. bskpWT, ramRWT, acrbWT, yeiUWT, rfaYWT indicate on a WT allele. cHA indicates on an HA epitope tag that
was attached to the C terminus of the gene. ND indicates not determined.
facilitates the translocation of membrane proteins from the inner
to the outer membrane, preventing protein aggregation in the
periplasmic space (Schafer et al., 1999). RL1 carried a deletion
mutation in position 265,722, resulting in a frameshift that
eventually led to a premature stop codon within hlpA (Table 3).
The acrB gene encodes AcrB, the substrate-binding domain of
the AcrAB-TolC system, a multidrug efflux pump. This system
is mostly known to protect bacteria from bile salts, dyes, and
antibiotics such chloramphenicol and tetracycline (Adhya et al.,
1995; Yu et al., 2003). There is evidence that several AMPs are
substrates of the system. Two studies reported that deletion of
this system increased K. pneumoniae and E. coli susceptibility
to AMPs, respectively (Padilla et al., 2009; Warner and Levy,
2010). The AcrB mutation in RL1 is located at arginine 620, which
was replaced by serine (R620S). Based on previous structural
studies, this amino acid is located within a switch loop that allows
the conformational change of AcrB monomers and is important
for substrate access and binding (Eicher et al., 2012). We
compared the conservation of the switch loop sequence among
∼1,000 Gram-negative bacterial strains, which include ∼240
different species. We found that, generally, this domain is highly
conserved (Figure 1A). The R/Q620 position is well-conserved
and might indicate a functional importance (Figure 1A). ramR
encodes a transcriptional regulator which activity was previously
described in S. typhimurium LT2. Accordingly, RamR represses
the transcription of ramA, an activator of the acrA and acrB
expression (Abouzeed et al., 2008). In RL1, the mutation is
located at position 639,370, which led to substitution of threonine
19 with proline (T19P). This amino acid is located in the alpha
helix α1, a part of the protein DNA-binding domain (Yamasaki
et al., 2013). Because proline is known to disrupt alpha helical
structures (Li et al., 1996), it could potentially affect RamR’s ability
to bind the ramA promoter. Quantification of ramR transcripts
indicated a 7.8-fold increase in RL1 compared to the control
strain (Figure 1B). Yet, the acrB transcript levels were higher
in RL1 than in the control strain (Figure 1B), implying that the
repressive activity of RamR might be impaired in RL1.
The gene products of yeiU and rfaY are involved in LPS
biosynthesis. yeiU encodes the inner membrane protein LpxT,
which transfers a phosphate group to lipid A, forming the
1-diphosphate species (Touze et al., 2008). RL1 carries an SNP
mutation in yeiU, which resulted in a stop codon (Table 3).
Inactivation of this protein was shown to confer resistance
to AMPs due to reduction of the net negative surface charge
(Herrera et al., 2010; Kato et al., 2012). rfaY encodes WaaY,
which is involved in phosphorylation of the HepII of the LPS
core (Yethon et al., 1998). RL1 carries a deletion mutation
in this locus, which resulted in a frameshift effect (Table 3).
A frameshift mutation in this gene was previously reported to
evolve in experimental evolution that induced AMP resistance.
It was suggested that the reduction in the LPS net negative
charge weakens the interaction with positively charged AMPs
as a mechanism of resistance (Lofton et al., 2013). Because






aUnderlined amino acids refer to D enantiomers. bThis lipopeptide is composed of
an eight-carbon fatty acid (caprylic acid) attached to the K5L7 peptide.
TABLE 3 | Description of RL1’s mutations.
Gene Position Refa Altb Typec Effectd
hlpA (skp) 265722 AC A DEL Frameshift
acrB 531233 G T SNP Missense
ramR 639370 T G SNP Missense
yeiU 2364176 G A SNP Stop codon
rfaY 3925953 AT A DEL Frameshift
aThe nucleotide at the position in the reference genome of Salmonella enterica
serovar typhimurium 14028s. bThe nucleotide at the position in RL1 genome.
cThe type of mutation: DEL, deletion; SNP, single-nucleotide polymorphism. dThe
predicted effect of the mutation on the protein.
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FIGURE 1 | Characterization of the effect of mutations in acrB and ramR. (A) A consensus sequence logo of the switch loop was generated through
https://weblogo.berkeley.edu/ using the multiple sequence alignment tool CLUSTAL 2.1. Sequences of 998 Gram-negative bacterial species and strains were used.
(B) Quantitative reverse transcriptase-polymerase chain reaction (PCR) analysis of the relative expression of the ramR (left panel) and acrB (right panel) mRNA levels,
in mid-log phase bacteria. The values are average of three biological replicates, each performed in triplicates. Statistical analysis was done using t-test. ∗P < 0.05,
∗∗P < 0.01.
mutations with similar impact both in yeiU and rfaY were
already reported to confer resistance to AMPs, we focused on the
mutations in acrB, ramR, and skp and their possible contribution
to AMP resistance.
The Combination of Mutations in AcrB
and RamR Induces Hyposensitivity
Toward 4DK5L7 but Not to seg5D
To investigate whether the mutations in AcrB and RamR
contribute to resistance toward the 4DK5L7 peptide, we
generated mutants carrying RL1’s point mutations in acrB (acrB
mut), in ramR (ramR mut), and both of these mutations (double
mutant) (Table 3). Next, we compared the growth of the
control strain, RL1, acrB mut, double mutant, and ramR mut
in the presence of 4DK5L7 at the MIC of the control strain
(12.5 µM). As expected, RL1 showed a remarkable optimal
growth, whereas the control strain did not exhibit growth
(Figure 2A). The double mutant, having a MIC twofold higher
than the control strain (Table 1), showed a moderate growth,
which was significantly higher than the control strain but lower
than RL1 (Figure 2A). The acrB mut and the ramR mut bacteria
displayed a similar MIC to the control strain (Table 1), and
no significant differences between their growth curves were
observed (Figure 2A). As a negative control, bacteria were grown
without peptide and showed no significant differences in growth
(Figure 2B). Furthermore, we checked whether the mutations
contribute to resistance against seg5D, a peptide that RL1 showed
cross-resistance toward (Table 1). The MIC of the acrB mut,
ramR mut, and the double mutant was similar to that of the
control strain (Table 1). Accordingly, at the MIC of the control
strain (12.5 µM), RL1 exhibited an optimal growth, whereas none
of the mutants grew (Figure 2C). In the negative control, the
strains showed similar growth, whereas RL1 reached a slightly
lower OD600 value (Figure 2D). Based on the growth curves, we
calculated the growth rates of the strains in the presence of these
AMPs. We found that at 12.5 µM of 4DK5L7 the double mutant
and the acrB mut had similar low growth rates. However, the
double mutant was significantly different from the control strain,
whereas the acrB mut was not (Figure 2E). In addition, RL1’s
growth rate was only slightly reduced at 12.5 µM of 4DK5L7
(Figure 2E) and 12.5 µM of seg5D (Figure 2F) compared to the
growth rate in the absence of AMPs.
The AcrB Mutant Protein Is
Overexpressed in RL1 and the Double
Mutant
Next, we aimed to validate the protein expression levels of the
mutated AcrB and to test the impact of the mutation in ramR on
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FIGURE 2 | The effect of mutations in acrB and ramR on resistance and on AcrB protein levels. Growth curve of bacterial strains at 12.5 µM of (A) 4DK5L7 peptide
and (B) without peptide. Growth curve of bacterial strains at (C) 12.5 µM seg5D peptide or (D) without peptide. Growth rates of the strains at the different peptide
concentrations of (E) 4DK5L7 and (F) seg5D. OD600 was monitored every 20 min for 18 h. Statistical analysis was performed using Tukey multiple comparison test
for all the time points. Statistically significant differences are indicated as a6=b6=c, P < 0.05. The values are average of at least three biological replicates, each
performed in duplicates. Error bars indicate the standard error. (G) Left panel: acrB-HA protein levels in mid log phase bacteria were measured by western blot. The
control strain bacteria without the HA epitope tag was used as a negative control. Anti-GroEL antibody was used for loading control. Right panel: quantification of
the AcrB-HA relative expression, an average of three biological replicates. Statistical analysis was performed using Dunette multiple comparison analysis. ∗P < 0.05,
∗∗P < 0.01.
the protein level. For this purpose, an epitope tag was added to
the C-terminal end of the protein (Table 1). The addition of an
HA epitope tag to the AcrB protein did not affect the MIC toward
4DK5L7 among the mutants and the control strain (Table 1
and Supplementary Figure S1). Using Western blot analysis,
we found that the acrB mut and the control strain bacteria had
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similar AcrB-HA protein levels (Figure 2G). Bacteria carrying the
point mutation in the ramR gene (RL1, double mutant, and ramR
mut) showed a significant higher levels of AcrB than the control
strain (a fold change of 2.2–2.9) (Figure 2G). This fold change is
similar to the elevation in the acrB transcripts that were measured
in RL1 (Figure 1B).
The Mutation in RamR Induced
Hyposensitivity Toward Chloramphenicol
and Ampicillin While the Mutation in
AcrB Induced Hypersusceptibility
Toward Ampicillin
Because the AcrAB-TolC system was mostly studied in the
context of resistance to antibiotics, we evaluated the impact of
RL1’s mutations on the MIC of chloramphenicol and ampicillin
compared to the control strain. We found that the mutation
in ramR increased the MIC of chloramphenicol and ampicillin,
whereas the mutation in acrB reduced the MIC of ampicillin
(Table 4). More specifically, at 5.8 µM (1 × MIC of the control
strain), no growth was observed for the control strain, RL1
and acrB mut. This is in contrast to the double mutant and
the ramR mut (Figure 3A). At 2.9 µM (0.5 × MIC of the
control strain), RL1 and the acrB mut were hyposensitive to
chloramphenicol compared to the other strains (Figure 3B). At
1.45 µM (0.25 ×MIC of the control strain), all the strains grew,
while RL1 was yet hyposensitive to chloramphenicol than the
others (Figure 3C). No significant differences in growth were
observed in the absence of chloramphenicol (Figure 3D). In
the case of ampicillin, we found more significant impact of the
mutation in acrB on the MIC values (Table 4). At 33.6 µM
(1 × MIC of the control strain), ramR mut was the only strain
that exhibited growth (Figure 3E). At 16.8 µM (0.5×MIC of the
control strain), the control strain, double mutant, and ramR mut
exhibited growth, whereas RL1 and acrB mut did not (Figure 3F).
At 8.4 µM (0.25 × MIC of the control strain), all the strains
showed growth, whereas RL1 and acrB mut were slightly more
susceptible (Figure 3G). In the absence of ampicillin, all strains
grew similarly, whereas the control strain exhibited a minor
advantage (Figure 3H).
The Mutation in skp Induced
Hyposensitivity to 4DK5L7 and Cross
Resistance Toward seg5D
To investigate whether the mutation in skp contributes to
resistance to AMPs, we introduced this point mutation in the
TABLE 4 | MIC to antibiotics.
Control RL1 acrB Double ramR
strain RL1 mut mutant mut
Chloramphenicol (µM) 5.8 2.9–5.8 2.9–5.8 11.6 11.6
Ampicillin (µM) 33.6 16.8–33.6 16.8 33.6 67.2
The values are representative data from three biological replicates, each
performed in duplicates.
control strain background (skp mut) and in the double-mutant
background (triple mutant) (Table 1). We found that the MIC to
4DK5L7 was increased by twofold in the skp mut and by fourfold
in the triple mutant. A comparison between the growth curves
of the different strains revealed that at 25 µM (2 × MIC of the
control strain) RL1 showed an optimal growth, and the triple
mutant showed a suboptimal growth (Figure 4A). The other
bacterial strains did not exhibit any growth at this concentration
(Figure 4A). At 12.5 µM (1×MIC of the control strain), RL1 and
the triple mutant showed a similar optimal growth (Figure 4B).
The skp mut and the double mutant showed a similar moderate
growth, whereas the control strain did not grow (Figure 4B). At
6.25 µM (0.5 × MIC of the control strain) and without peptide,
no significant differences were observed between the five strains
(Figures 4C,D, respectively). The growth rates of RL1 and the
triple mutants were similar at the different peptide concentrations
(Figure 4E). The skpmut and the double mutant exhibited similar
growth rates that were lower compared to RL1 and the triple
mutant at 12.5 µM (Figure 4E). Next, we tested the impact of
the mutation in skp on the MIC of the seg5D peptide. We found
that the MIC of the skp mut and the triple mutant increased by
fourfold (Table 3). Comparison between the growth curves of
the strains demonstrated that the skp mut and the triple mutant
showed a moderate growth at 25 µM (2 × MIC of the control
strain) (Figure 5A). RL1 showed an optimal growth, whereas the
control strain and the double mutant did not grow (Figure 5A).
At 12.5 µM (1×MIC of the control strain) RL1, skp mut and the
triple mutant showed similar optimal growth, whereas the control
strain and the double mutant did not exhibit growth (Figure 5B).
At 6.25 µM (0.5 × MIC of the control strain) RL1, skp mut and
the triple mutant reached higher OD600 levels compared to the
control strain and the double mutant (Figure 5C). No significant
differences between the growth curves of the five strains were
observed without peptide (Figure 5D). The growth rates at
the different concentrations of seg5D were similar between the
control strain and the double mutant and between the skp
mut and the triple mutant (Figure 5E). The growth rates of
RL1 were mostly similar to the skp mut and the triple mutant
except of the growth rate at 25 µM, which was higher for RL1
(Figure 5E). We further tested the growth in the presence of
other AMPs and observed variations in growth at sub-inhibitory
concentrations. In the presence of 3.125 µM C8-K5L7 peptide
(0.5 × MIC of the control strain) RL1, skp mut and the triple
mutant had growth advantages due to a shorter lag phase and
higher maximal OD600 values compared to the control strain
and the double mutant (Figure 6A). We also found differences
in growth in the presence of 1.56 µM colistin (0.5 × MIC of
the control strain). RL1 showed an optimal growth, and skp
mut showed a slightly slower growth than RL1 (Figure 6B).
The triple mutant and the control strain showed similar growth
(Figure 6B). The double mutant showed a negligible growth
under these conditions, suggesting colistin hypersusceptibility of
that strain (Figure 6B). Once more, no differences were observed
between the strains in the absence of peptides (Figure 6C). The
growth rates of the control strain were significantly reduced at
1.56 µM of colistin or 3.125 µM of C8-K5L7, opposed to RL1,
skpmut, and the triple mutant (Figure 6D). Moreover, the growth
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FIGURE 3 | The mutation in ramR induced hyposensitivity to chloramphenicol and ampicillin, whereas the mutation in acrB induced hypersusceptibility to ampicillin.
Bacteria were grown overnight with antibiotics at 37◦C to determine their minimal inhibitory concentration (MIC) to chloramphenicol or ampicillin. OD600 of the
control strain RL1, acrB mut, double mutant, and ramR mut was measured following 18 h. OD600 of bacteria grown with chloramphenicol at concentration of (A)
5.8 µM, (B) 2.9 µM, (C) 1.8 µM, and (D) at the absence of chloramphenicol. OD600 of bacteria grown with ampicillin at concentration of (E) 33.6 µM, (F) 16.8 µM,
(G) 8.4 µM, and (H) at the absence of ampicillin. The values are average of three biological replicates; each was performed in duplicates. Statistical analysis was
performed using Tukey multiple-comparisons test. Statistically significant differences are indicated as a6=b6=c, P < 0.05.
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FIGURE 4 | The mutation in skp-induced hyposensitivity to the 4DK5L7 peptide. Growth curves of bacterial strains with the 4DK5L7 peptide at (A) 25 µM, (B)
12.5 µM, (C) 6.25 µM, and (D) without peptide. (E) Growth rates of the strains at the different peptide concentrations. OD600 was monitored every 20 min for 18 h.
The values are average of at least three biological replicates, each performed in duplicates. Error bars indicate the standard error. Statistical analysis was performed
using Tukey multiple-comparisons test for the last five the time points. Statistically significant differences are indicated as a6=b6=c6=d, P < 0.05.
rate of the double mutant was significantly reduced at 1.56 µM of
colistin compared to all the other strains (Figure 6D). Overall,
the skp mutation induced hyposensitivity toward 4DK5L7 and
C8-K5L7 and resistance toward seg5D. The double mutant
showed hyposensitivity toward 4DK5L7 and hypersusceptibility
to colistin. A combination of the three mutations in ramR, acrB,
and skp resulted in a significant resistance to the 4DK5L7 peptide.
The Mutation in skp Led to the Loss of
the Skp Protein and Influenced Multiple
Cellular Pathways
In Gram-negative bacteria, 35% of the proteome is directed to
the inner and the outer membrane (Mas et al., 2019). Since Skp
plays a key role in OMP translocation, we hypothesized that
its mutation would have a significant impact on the proteome.
Moreover, we aimed to shed light on the resistance mechanism
to AMPs of this genotype. We analyzed the proteome of the
control strain, RL1, and the skp mut strains. Single-protein
analysis and pathway analysis, based on the KEGG database,
were conducted. First, we found that the Skp protein was
expressed in the control strain, but not in RL1 or the skp
mut bacteria (Supplementary Table S2). This suggests that
the mutation led to the loss of this protein. Unlike in the
control strain and skp mut strains, we did not detect the
LPS biosynthesis gene products of yeiU and rfaY in RL1
(Supplementary Table S2). The RamR protein was found to
be expressed similarly among the three strains, suggesting that
the ramR mutation did not influence protein stability but
rather impaired its activity. According to the KEGG database,
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FIGURE 5 | skp mut but not the double mutant is hyposensitive to the seg5D peptide. Growth curves of bacterial strains with the seg5D peptide at (A) 25 µM, (B)
12.5 µM, (C) 6.25 µM, and (D) without peptide. (E) Growth rates of the strains at the different peptide concentrations. OD600 was monitored every 20 min for 18 h.
The values are average of at least three biological replicates, each performed in duplicates. Error bars indicate the standard error. Statistical analysis was performed
using Tukey multiple-comparisons test for all the time points. Statistically significant differences are indicated as a6=b6=c6=d6=e, P < 0.05.
we found that proteins of the cationic antimicrobial peptide
(CAMP) resistance pathway were enriched in RL1 and skp mut
proteomes compared to the control strain (Figure 7). This was
reflected by elevation in HtrA (DegP) both in RL1 and the skp
mut, compared to the control strain. This protein is known
to play a role along with Skp in OMP translocation through
the periplasm (Sklar et al., 2007). Additional proteins in the
CAMP resistance pathway that were up-regulated in RL1 but
not in the skp mut are ArnD, YcfS, AcrA, AcrB, and TolC
(Supplementary Table S3). The up-regulation of AcrB in RL1
due to the mutation in ramR is consistent with our Western
blot analysis (Figure 2B) and could also explain the elevation
in AcrA levels, as acrA and acrB are cotranscribed from a
single operon (Yamasaki et al., 2013). A depletion in β-lactam
resistance pathway was observed in RL1 and skp mut (Figure 7),
which was enunciated by the reduction of OMPs. A significant
reduction in OmpC was observed for skp mut, whereas in RL1
additionally OmpF was significantly depleted (Supplementary
Table S3). According to the single-gene analysis, we observed a
more extensive effect of the skp mutation on OMPs. We found a
significant reduction of OmpC, OmpD, and OmpF levels both
in RL1 and in the skp mut compared to the control strain
(Supplementary Table S2). However, some OMPs exhibited
higher levels in RL1 and skp mut compared to control strain.
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FIGURE 6 | Mutation in skp improved the growth in sub-minimal inhibitory concentration concentrations of C8-K5L7, whereas double mutant was hypersusceptible
to colistin. Growth curves of bacterial strains (A) with C8-K5L7 at 3.125 µM, (B) with colistin at 1.56 µM, or (C) without peptide. (D) Growth rates of the strains at
the different peptide concentrations. OD600 was monitored every 20 min for 18 h. The values are average of at least three biological replicates, each performed in
duplicates. Error bars indicate the standard error. Statistical analysis was performed using Tukey multiple-comparisons test for all the time points. Statistically
significant differences are indicated as a6=b6=c6=d, P < 0.05.
Amounts of OmpX and OmpA were higher in the skp mut
compared to the control strain, and OmpR and OmpN were
found to be more abundant in RL1 compared to the control strain
(Supplementary Table S2). Other cellular pathways that were
enriched in RL1 and skp mut in comparison to the control strain
are as follows: microbial metabolism in diverse environments,
purine metabolism, selenocompounds metabolism, and sulfur
metabolism, which were mostly reflected in up-regulation of
the genes in the L-cysteine synthesis pathway (Supplementary
Table S3). Compared to the control strain and the skp mut,
RL1 showed depletion of proteins that are part of the bacterial
chemotaxis, flagellar assembly, TCS, and Salmonella infection
pathways. RL1 showed enrichment in the proteins of the β-lactam
resistance, CAMP resistance, and starch and sucrose metabolism
pathways (Figure 7). Proteins of the propanoate metabolism
pathway were depleted in the skp mut compared to the control
strain and to RL1 (Figure 7). The enrichment of the bacterial
secretion system in RL1 compared to the skp mut was reflected
by elevation in TolC levels (Supplementary Table S3). To
summarize, the skp mutation led to the loss of Skp and had a
widespread influence on the proteome. Importantly, Skp loss led
to a significant reduction in OMPs and to elevation in DegP.
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FIGURE 7 | Differences in KEGG cellular pathways between the control strain, RL1, and the skp mut. Depletion (left) or enrichment in cellular pathways in the ratio of
control strain/RL1 (upper), control strain/skp mut (middle), or RL1/skp mut (lower). The analysis was performed for mid-log phase bacteria based on three
independent replicates for each strain.
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Compared to the skp mut, RL1 differs more from the control
strain in the cellular pathways, apparently, due to additional
mutations it carries.
DISCUSSION
The mutant RL1, isolated after experimental evolution through
exposure to the 4DK5L7 AMP, exhibited high level of resistance
to this AMP and cross-resistance to others. The resistance is
mediated by five spontaneous mutations that were evolved in
RL1. Two of the mutations were in LPS biosynthesis genes, yeiU
and rfaY, previously reported to mediate resistance to AMPs by
reduction of the surface net negative charge. To our knowledge,
the other three mutations that were evolved in RL1 were novel in
the context of AMP acquired resistance. We observed that these
three mutations mediate resistance to AMPs by two independent
mechanisms: one mechanism is drug specific and hence induces
hyposensitivity against 4DK5L7 peptide solely, whereas the other
mechanism induces hyposensitivity or resistance to multiple
AMPs. This strategy of evolving drug-specific and non-specific
resistance mechanisms is widely common and was reported
previously (Toprak et al., 2011).
Both mechanisms induce only a twofold change in the
MIC to the AMP 4DK5L7. These mutations were fixed in the
population despite their small contribution, indicating that each
conferred a selective advantage. This could be derived from
the design of the experimental evolution in which the peptide
concentration was increased by merely 50% gradually. The
first mechanism involves the AcrAB-TolC system, a multidrug
resistance efflux pump that was reported to remove mostly
antibiotics, bile salts, and dyes in Gram-negative bacteria (Yu
et al., 2003; Pos, 2009) and AMPs in E. coli (Warner and
Levy, 2010) and K. pneumonia (Padilla et al., 2009). Here we
show that this efflux pump confers resistance to AMPs in
S. typhimurium as well. The AcrB R620S mutation is within
a switch loop, which was found to be important for substrate
transport (Eicher et al., 2012). Mutations in several positions
in the switch loop (Bohnert et al., 2008; Wehmeier et al., 2009;
Cha et al., 2014) and specifically in the R620 position (Ababou
and Koronakis, 2016) have been shown to lead to susceptibility
to antibiotics. To our knowledge, we are the first to report that
mutation within the switch loop induced hyposensitivity toward
an AMP. This phenotype was dependent on an additional point
mutation T19P in RamR, which led to elevated AcrB levels.
Accordingly, the mutation in RamR induced hyposensitivity
toward chloramphenicol and ampicillin, well-known substrates
of the AcrAB-TolC system (Lim and Nikaido, 2010; Yamamoto
et al., 2016). Moreover, we found that the AcrB R620S mutation
increased the susceptibility to ampicillin and colistin, indicating
that the efflux ability of these two compounds was impaired. RL1
was slightly more susceptible to chloramphenicol and ampicillin
compared to the double mutant, although both strains carry
mutations in ramR and acrB. This could be derived from the
fact that RL1 carries additional mutations in LPS biosynthesis
genes. Lipopolysaccharide serves as a barrier to antibiotics, and
alterations in the LPS composition were previously shown to
cause susceptibility to antibiotics (Vaara and Nurminen, 1999;
Snyder and McIntosh, 2000; Nikaido, 2005; Li et al., 2012).
Overall, we suggest that this resistance mechanism involves
up-regulation of AcrB through impaired activity of the RamR
protein. Thus, elevated levels of mutated AcrB enabled the
bacteria to more efficiently extrude the 4DK5L7 peptide. Notably,
AcrB substrate sizes vary in the range of several 100 Da. Among
the largest substrates reported for the AcrAB-TolC system is
bleomycin (Cha et al., 2014). The 4DK5L7 peptide is similar in
size to bleomycin, supporting the ability of the efflux pump to
transport this AMP.
The second new resistance mechanism is associated with
the hlpA gene, encoding the Skp periplasmic chaperone. To
our knowledge, this gene was never reported to be involved in
AMP resistance. We found that the mutation in this gene led
eventually to a premature stop codon, thus to the loss of Skp. This
induced hyposensitivity to the 4DK5L7 and C8-K5L7 peptides
and conferred resistance to seg5D. Interestingly, the resistance
to seg5D was more significant than to 4DK5L7, as the MIC was
increased fourfold for seg5D compared to twofold for 4DK5L7.
This outcome highlights the problem of cross-resistance, which
is unexpected and in some cases could be more severe than the
resistance to the antibiotic that induced it. Skp, DegP, and SurA
are the major three periplasmic chaperones of Gram-negative
bacteria that escort OMPs during translocation from the inner
to the outer membrane. Skp is a chaperone of the “holdases”
family, which prevents substrate aggregation through binding in
its cavity, but without directly assisting folding (Walton et al.,
2009; Entzminger et al., 2012). DegP is a chaperone/protease
with a temperature switch; whereas at low temperatures it has
a chaperone activity, in heat shock it has a protease activity
(Spiess et al., 1999). In S. typhimurium, DegP was found to
be important in oxidative stress response and for survival and
virulence in mice (Johnson et al., 1991; Humphreys et al., 1999;
Mo et al., 2006). The SurA chaperone has a role in OMP folding
along with a peptidyl-prolyl isomerase activity (Goemans et al.,
2014). To date, the exact contribution of each chaperone to
OMP biogenesis is still controversial. According to one model,
Skp/DegP and SurA are two parallel redundant pathways for
OMP translocation through the periplasm (Rizzitello et al.,
2001). Another model suggests that Skp/DegP rescues OMPs
that fall off SurA (Sklar et al., 2007). Alternatively, it was
suggested that Skp and SurA act sequentially in the same
pathway (Bos and Tommassen, 2004). Nevertheless, previous
reports demonstrated that Skp depletion in E. coli had a
negligible impact on OMP levels (Sklar et al., 2007; Denoncin
et al., 2012). In contrast, we observed that the loss of Skp led
to a significant reduction in major OMPs including OmpC,
OmpF, and OmpD. It is possible that the role of Skp in
S. typhimurium is more essential than in E. coli. A similar
phenotype was observed in Neisseria meningitidis, where Skp
depletion resulted in a severe reduction in the major OMPs
(Volokhina et al., 2011). Misfolded OMP stress is detected by
the CpxA/R TCS or by the alternative sigma factor σE, both of
which up-regulate the transcription of DegP (Masi et al., 2019).
Accordingly, we found that RL1 and skp mut expressed higher
levels of DegP compared to the control strain. It was previously
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shown that DegP has a relation to the CAMP resistance pathway,
possibly through assisting the assembly of transporters that
mediate efflux of AMPs (Weatherspoon-Griffin et al., 2014) or
by proteolytic degradation (Ulvatne et al., 2002). It is possible
that resistance to AMPs in the skp mut is derived from the up-
regulation of DegP. However, it is less likely that the resistance
mechanism involves proteolytic degradation as both 4DK5L7
and the seg5D contain D amino acids, which were shown
to protect them against proteolytic degradation (Papo et al.,
2002; Papo and Shai, 2005). Therefore, it is possible that DegP
functions in the support of biogenesis of membrane-associated
multidrug transporters that mediate resistance to those AMPs.
Nonetheless, we cannot rule out that other cellular pathways that
were affected both in RL1 and the skp mut or the alterations in
bacterial envelope due to the periplasmic stress confer resistance
to the studied AMPs.
CONCLUSION
Antimicrobial peptides resistance can be a complex
multimechanistic phenotype involving multiple genes. Here we
report on a multimechanism resistance that involves mutations
in five genes; three of the mutations are associated with AMP
acquired resistance for the first time. Our data reveal two
parallel resistance mechanisms that were evolved in RL1. The
first mechanism involves two mutations, which resulted in
overexpression of a mutated AcrB protein, which together
improved the efflux of 4DK5L7. However, this resistance
mechanism had a cost, as bacteria became hypersusceptible
to ampicillin and colistin. The second mechanism induced
hyposensitivity to multiple AMPs and was achieved by a mutation
in skp, which abolished this protein. This led to a reduction in
OMPs and to elevation in DegP and influenced multiple cellular
pathways. Further investigations are required to confirm the
molecular mechanism conferring resistance to AMPs by the
skp mutation.
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FIGURE S1 | HA mutants with 4DK5L7. Growth curves of the bacteria with the
4DK5L7 peptide at (A) 25 µM, (B) 12.5 µM, (C) 6.25 µM, and (D) without
peptide. OD600 was monitored every 20 min for 18 h. The values are average of at
least three biological replicates, each performed in duplicates. Error bars indicate
the standard error. Statistical analysis was performed using Tukey multiple
comparison test for the last five the time points. Statistically significant differences
are indicated as a6=b6=c, P < 0.05.
TABLE S1 | Primers that were used in this study.
TABLE S2 | Description of the genes that were depleted or enriched according to
the single gene analysis.
TABLE S3 | Description of the genes that were depleted or enriched according to
the KEGG pathways database analysis.
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